Post-Market Optimization Study of the EMPOWER® RF Catheter to Ablate Soft Tissue Lesions in the Lung

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
A post-market study to assess the performance and safety of a RF ablation catheter to bronchoscopically ablate lung lesions will be evaluated in patients with confirmed diagnosis of non-small cell lung cancer or metastatic lung lesions who are scheduled for surgical resection.
Epistemonikos ID: 142eb433e376265a337695be308f369f26ffdd60
First added on: May 22, 2024